AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ETANERCEPT
23 registrations across 5 African markets— 21 active
Markets with ETANERCEPT
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| NEPEXTO 50 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| VENCEPA 25 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| ETREAPEXT 50 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| ETREAPEXT 50 PREFILLED PEN | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| NEPEXTO 50 PREFILLED PEN | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| NEPEXTO 25 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| VENCEPA 50 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| VENCEPA 50 PREFILLED PEN | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| ETREAPEXT 25 PS | 🇿🇦South Africa | Imperial Market Access Healthcare SA (Pty) Ltd | active | Aug 2028 |
| ENBREL | 🇬🇭Ghana | — | active | Apr 2028 |
| ENBREL | 🇬🇭Ghana | — | active | Apr 2028 |
| NEPEXTO SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN PHARMACEUTICALS PVT LTD | active | Dec 2027 |
| NEPEXTO SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN PHARMACEUTICALS PVT LTD | active | Dec 2027 |
| NEPEXTO SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN PHARMACEUTICALS PVT LTD | active | Dec 2027 |
| ENBREL Solution injectable / 50 mg | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Sept 2020 |
| ENBREL Solution injectable / 25 mg | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Sept 2020 |
| ENBREL 25 mg PS | 🇿🇦South Africa | PFIZER LABORATORIES PFE (PTY) LTD | active | Jan 1900 |
| ENBREL 50 mg PS | 🇿🇦South Africa | PFIZER LABORATORIES PFE (PTY) LTD | active | Jan 1900 |
| ENBREL 25 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| ERELZI 25 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| ERELZI 50 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| ENBREL 25MG SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ENBREL 25MG SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
ETANERCEPT in Africa — Regulatory Overview
ETANERCEPT is registered across 5 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Ghana, Morocco and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 21 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.